Global Peptide Therapeutics Market 2019-2023
|出版商||TechNavio (Infiniti Research Ltd.)||商品編碼||317311|
|出版日期||內容資訊||英文 118 Pages
|肽治療藥的全球市場:2019年∼2023年 Global Peptide Therapeutics Market 2019-2023|
|出版日期: 2018年12月24日||內容資訊: 英文 118 Pages||
全球肽治療藥市場，由於癌症、糖尿病、肥胖、心血管疾病等的慢性疾病的增加等而成長。肽對這些疾病的治療表現高效果。該市場預測至2023年將以9％的年複合成長率 (CAGR) 擴大。
One of the major drivers of the global peptide therapeutics market is the growing cases of chronic diseases such as cancer, diabetes, obesity, and various cardiovascular diseases. Peptides are known to have high efficacy in the treatment of these diseases. Hence the use of peptides has increased significantly in recent years with the growing prevalence of chronic conditions. The high prevalence of chronic conditions leads to significant demand for curative drugs such as peptides thereby driving market growth. Moreover, the significant need for the treatment of these diseases has led various pharmaceutical companies to develop therapies, including peptide-based drugs. Technavio's analysts have predicted that the peptide therapeutics market will register a CAGR of almost 9% by 2023.
Currently the treatment of various diseases with peptides is predominantly done by administering drugs through the parenteral route. The parenteral RoA is considered to be one of the most undesirable routes for patients due to the invasive nature of the drug administration. Hence. vendors are focusing on developing better drug delivery systems. The increasing need for novel drug delivery systems has led to the development of self-injectable pens by various vendors.
One of the major challenges faced by the global peptide therapeutics market is the stringent policies set by regulatory bodies globally. The policies set for the approval of biologic drugs by regulatory bodies are more stringent than for small molecules, which makes it difficult for pharmaceutical companies to launch these drugs in the market. The late launch of drugs or FDA refusal of a drug can hinder the growth of the market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the peptide therapeutics market during the 2019-2023, view our report.
The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.